Headless Myo10 Is a Negative Regulator of Full-length Myo10 and Inhibits Axon Outgrowth in Cortical Neurons by Raines, Alexander N. et al.
Headless Myo10 Is a Negative Regulator of Full-length Myo10
and Inhibits Axon Outgrowth in Cortical Neurons*□S
Received for publication, April 4, 2012, and in revised form, May 25, 2012 Published, JBC Papers in Press, May 31, 2012, DOI 10.1074/jbc.M112.369173
Alexander N. Raines‡§, Sarbajeet Nagdas¶, Michael L. Kerber¶, and Richard E. Cheney§¶1
From the ‡Curriculum in Neurobiology, §Neuroscience Center, and ¶Department of Cell and Molecular Physiology, University of
North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599
Background:A “headless”Myo10 that lacks amotor domain has been identified in the nervous system, but its functions are
unknown.
Results: Headless Myo10 inhibits axon outgrowth and antagonizes the filopodia-inducing activity of full-length Myo10.
Conclusion: Full-length Myo10 is required for axon outgrowth, and headless Myo10 can inhibit full-length Myo10.
Significance: This study establishes opposing roles for headless and full-length Myo10 in axon outgrowth.
Myo10 is an unconventional myosin that localizes to and
induces filopodia, structures that are critical for growing axons.
In addition to the240-kDa full-lengthMyo10, brain expresses
a165 kDa isoform that lacks a functionalmotor domain and is
known as headless Myo10. We and others have hypothesized
that headless Myo10 acts as an endogenous dominant negative
of full-length Myo10, but this hypothesis has not been tested,
and the function of headless Myo10 remains unknown.We find
that cortical neurons express both headless and full-length
Myo10 and report the first isoform-specific localization of
Myo10 in brain, which shows enrichment of headless Myo10 in
regions of proliferating and migrating cells, including the
embryonic ventricular zone and the postnatal rostral migratory
stream. We also find that headless and full-length Myo10 are
expressed in embryonic and neuronal stem cells. To directly test
the function of headless and full-length Myo10, we used RNAi
specific to each isoform in mouse cortical neuron cultures.
Knockdown of full-length Myo10 reduces axon outgrowth,
whereas knockdown of headless Myo10 increases axon out-
growth.To testwhether headlessMyo10 antagonizes full-length
Myo10, we coexpressed both isoforms in COS-7 cells, which
revealed that headlessMyo10 suppresses the filopodia-inducing
activity of full-length Myo10. Together, these results demon-
strate that headless Myo10 can function as a negative regulator
of full-length Myo10 and that the two isoforms of Myo10 have
opposing roles in axon outgrowth.
Nervous systemdevelopment requires the precise outgrowth
of axons to their targets, a process that depends on the growth
cone. Growth cones are specialized protrusive structures stud-
ded with filopodia, finger-like protrusions with an actin core
that sample the surrounding tissue for guidance cues and trans-
form these signals into directed outgrowth.Myosin-X (Myo10)
is an unconventional myosin that has critical functions in filo-
podia (1). Myo10 localizes to the tips of filopodia (2–6), moves
within filopodia (6–10), and induces the formation of filopodia
(4, 6, 7, 10, 11). Given the importance of filopodia in neuronal
development, particularly in axon outgrowth and branching
(12–15), Myo10 is likely to have critical functions in neuronal
development. Myo10 may also participate in nerve regenera-
tion, as it is up-regulated 7-fold in peripheral neurons during
recovery from axotomy (16).
The tail region of Myo10 contains a unique array of domains
reported to bind tomolecules with prominent roles in neuronal
function. A region containing three pleckstrin homology (PH)
domains can bind phosphatidylinositol (3,4,5)-triphosphate
and interact with the plasma membrane (4, 17), and Myo10
functions downstream of PI3K in macrophage phagocytosis
(18). Recently, phosphatidylinositol (3,4,5)-triphosphate bind-
ing was shown to convert Myo10 from a compact, autoinhib-
ited monomer to an active dimer (5), demonstrating that
Myo10 motor activity can be regulated by the PI3K pathway.
The myosin tail homology 4 (MyTH4) domain of Myo10 can
bindmicrotubules and is required for proper spindle formation
(19–23). By binding both actin and microtubules, Myo10 may
mediate actin-microtubule interactions, which are important
for axon outgrowth and branching (13, 24–26). TheMyo10 tail
region ends in a band4.1/ezrin/radixin/moesin (FERM) domain
that can interact with -integrins (27), positioning Myo10 to
act as a molecular link between filopodial actin and the extra-
cellular matrix.
The FERM domain of Myo10 can also bind to deleted in
colorectal carcinoma (DCC)2 and neogenin, receptors for the
guidancemolecule netrin (23, 28, 29).Myo10 is required for the
distribution of DCC to the periphery (28), whereas DCC and
neogenin have different effects on the type of filopodia induced
by Myo10 (6). In the chicken spinal cord, shRNA to Myo10
impaired crossing of commissural axons across the midline
(28), although it is not clear whether this defect resulted from
incorrect guidance or insufficient outgrowth. Overexpression
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of a motorless Myo10 construct also inhibited commissural
axon crossing (28).
Although motorless Myo10 constructs have been used as
presumed dominant negatives (18, 28, 30), brain uses an alter-
nate transcription start site to endogenously express a similar
isoform, termed “headless”Myo10 (31). This headlessMyo10 is
missing most of the motor domain and thus lacks the key func-
tional characteristic of a myosin: the ability to bind to actin
filaments and exert force. Unlike the full-length protein, head-
less Myo10 does not localize to filopodial tips and does not
undergo intrafilopodial motility (9, 31). Although headless
Myo10 is hypothesized to act as an endogenous dominant neg-
ative (31), this hypothesis has never been tested directly.
Here we show that both full-length and headless Myo10 are
expressed in embryonic mouse cortex and cultured cortical
neurons. Surprisingly, headlessMyo10 is also expressed in neu-
ral stem cells, and in situ hybridization reveals that headless
Myo10 is most prominently expressed in the embryonic ven-
tricular zone. We also report the first specific knockdown of
headlessMyo10, which significantly increases the outgrowth of
axons of cultured cortical neurons. Knockdown of full-length
Myo10 has the opposite effect, inhibiting axon outgrowth. We
also demonstrate that headless Myo10 antagonizes the induc-
tion of filopodia by full-length Myo10, showing that headless
Myo10 can indeed function as a dominant negative.
EXPERIMENTAL PROCEDURES
Animals—Mice were used according to a protocol approved
by the Institutional Animal Care and Use Committee at the
University of North Carolina at Chapel Hill and in accordance
with National Institutes of Health guidelines. Time-pregnant
females were obtained from Charles River Laboratories.
Ex Vivo Electroporation and Dissociated Cortical Neuron
Cultures—Mouse cortical progenitors were electroporated ex
vivo at embryonic day 15 (E15) and cultured as described pre-
viously (32, 33). Embryos were harvested from time-pregnant
BALB/c mice and decapitated in ice-cold Hanks’ balanced salt
solution (Invitrogen)with 2.5mMHepes (pH7.4), 30mMD-glu-
cose, 1 mM CaCl2, 1 mM MgSO4, 4 mM NaHCO3. Endotoxin-
free plasmid plus 0.5% Fast Green (Sigma) was injected into the
lateral ventricles using a PicoSpritzer III (General Valve)micro-
injector. The whole head was electroporated using an ECM830
electroporator with gold-plated electrodes (GenePads 5  7
mm, BTX). Immediately after electroporation, the brain was
removed, and the cortices dissected in ice-cold complete
Hanks’ balanced salt solution. The cortices were dissociated
using papain and cultured on glass-bottom dishes (MatTek)
coated with poly-L-lysine and laminin (Sigma) in serum-free
medium (Neurobasal with 1% penicillin/streptomycin, L-glu-
tamine, and B27 and N2 supplements, Invitrogen).
Cell Culture and Transfection—Cell culture reagents were
obtained from Invitrogen unless noted otherwise. Neural stem
cells were cultured as neurospheres from E15 cortex (34). The
cortices were dissected and dissociated as described above and
then cultured in Neurobasal medium with 1% penicillin/strep-
tomycin, L-glutamine, B-27 and N-2 supplements, epidermal
growth factor, and basic fibroblast growth factor. Astrocytes
were cultured from E17 rat embryos and subcultured at 13 days
in vitro at100,000 cells/cm2. The glioblastoma cell lines U-87
and U-138 were maintained in Eagle’s minimum essential
medium with 0.1 mM non-essential amino acids, 1 mM sodium
pyruvate, 10% FBS, 1% penicillin/streptomycin. P19 embryonal
carcinoma cells were cultured in DMEM plus 10% FBS and 1%
penicillin/streptomycin. COS-7 cells were maintained in
DMEM plus 10% FBS and 1% penicillin/streptomycin. COS-7
cells were transfected using Lipofectamine 2000 (Invitrogen)
according to the specifications of the manufacturer.
Tissue Samples and Immunoblotting—Tissue samples were
flash-frozen in liquid nitrogen and stored at 80 °C until all
sampleswere collected. The sampleswere thenhomogenized at
full speed for30 s (OmniTH,Omni International) on ice in 10
ml/g of homogenization buffer (40mMHepes, 10mMK-EDTA,
5 mM ATP, 2 mM DTT, 2 EDTA-free complete protease
inhibitor mixture (pH 7.7), Roche Diagnostics). For cellular
lysates, cultured neurons were scraped from the dish into ice-
cold lysis buffer (40 mM Hepes (pH 7.4), 75 mM KCl, 2 mM
K-EGTA, 1% Triton X-100, 2.5 mM MgCl2, 5 mM ATP, 2 mM
DTT, 2 EDTA-free complete protease inhibitor). Neuro-
sphere cultures of neural stem cells were centrifuged, rinsed
with PBS, and resuspended in ice-cold lysis buffer, whereas all
other cell types were trypsinized before centrifuging, rinsing,
and resuspending in ice-cold lysis buffer. Lysates were passed
through a 27.5-gauge syringe 6 times to shear DNA, combined
with 1/4th volume SDS sample buffer (5 stock: 300 mM Tris-
HCl, 10% SDS, 50% glycerol, 0.04% bromphenol blue, 50 mM
DTT (pH 6.8)), and immediately heated at 95 °C for 5–10 min.
All samples were run on NuPAGE 4–12% Bis-Tris gels in
NuPAGE MOPS SDS running buffer with the Novex Xcell
SureLock mini-cell system (Invitrogen) at 120 V for 100 min.
The gels were transferred onto nitrocellulose membranes (GE
Water and PurificationTechnologies) with theNovexmini-cell
system at 30 V for 3 h at 4 °C. Themembranes were blocked for
1 h in 5% milk (Carnation nonfat instant dry milk, Nestle) in
TBST (50 mM Tris (pH 7.5), 150 mM NaCl, 0.05% Tween 20).
Primary antibodies were diluted in blocking solution to a final
concentration of 1 g/ml of rabbit anti-Myo10 antibody
(Sigma, catalog no. HPA024223, made to amino acids 901–
1047 of human Myo10) and 0.5 g/ml of mouse monoclonal
anti-actin antibody (Millipore,MAB1501R) as a loading control
and incubated overnight at 4 °C. After washing 3 times with
TBST, the membranes were incubated for 1 h with secondary
antibodies (Rockland, goat anti-rabbit IRDye700Dx, goat anti-
mouse IRDye800Dx) diluted 1:10,000 in blocking solution for a
final concentration of 0.1 ng/ml. The membranes were then
washed once with TBST and 3 times with TBS before imaging
with a LiCor Odyssey infrared imaging system.
Immunoprecipitation andProtein Sequencing—Immunopre-
cipitation of Myo10 was carried out using a Dynabeads coim-
munoprecipitation kit with M-270 epoxy beads (Invitrogen)
following the protocol of the manufacturer. Briefly, 7.5 mg of
beads were covalently coupled to 75 g of affinity-purified rab-
bit anti-Myo10 antibody 505, which was raised against amino
acids 808–917 of mouse Myo10, by overnight incubation at
37 °C. Brain tissue (1 g) from P10 mice was then harvested and
homogenized in 5 ml of homogenization buffer as described
above. The homogenate was centrifuged for 20 min at 50,000
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rpm at 4 °C in a tabletop ultracentrifuge (Beckman-Coulter).
The supernatant was divided into two aliquots and incubated
with either non-immune control or Myo10 antibody-coupled
beads on a rotator for 1 h at 4 °C. The beads were washed with
200 l of homogenization buffer 3 times, once with 200 l of
the Dynal 1 last wash buffer, and transferred to a new tube.
The beads were resuspended in 60 l 1 PBS, combined with
15 l of SDS sample buffer, and heated at 95 °C for 5 min. The
samples were run on a 4–12% Bis-Tris gel as described above.
The Coomassie Blue-stained bands at 240 kDa and 165
kDa were excised from the gel, and in-gel trypsin digest was
performed using a ProGest protein digestion station (Digilab).
The extracted peptides were first mixed with matrix (-cyano-
4-hydroxycinnamic acid), spotted onto a MALDI plate, and
analyzed using a 4800 “Plus” MALDI-TOF/TOF mass spec-
trometer. The spectra were searched using MASCOT (Matrix
Science, version 2.3.02) to confirm that each sample contained
peptides fromMyo10.
The extracted peptides were then loaded onto a 2-cm long
360 m outer diameter  100 m inner diameter microcapil-
lary fused silica precolumn packed with Magic 5-m C18AQ
resin (Michrom Biosciences, Inc.). After sample loading, the
precolumnwas washed with 95% solvent A (0.1% formic acid in
water)/95% solvent B (0.1% formic acid in acetonitrile) for 20
min at a flow rate of 2 l/min. The precolumn was then con-
nected to a 360 m o.d.  75 m i.d. analytical column packed
with 14 cm of 5mof C18 resin constructed with an integrated
electrospray emitter tip. The peptides were eluted at a flow rate
of 250 nL/min by increasing the percentage of solvent B to 40%
with a Nano-Aquity HPLC solvent delivery system (Waters
Corp.). The LC systemwas directly connected through an elec-
trospray ionization source interfaced to an LTQ Velos ion trap
mass spectrometer (Thermo Electron Corp.). The mass spec-
trometerwas controlled byXcalibur software (Thermo, version
2.1.0.1140) and operated in the data-dependent mode in which
the initial MS scan recorded the mass to charge (m/z) ratios of
ions over the range 400–2000. The 10most abundant ionswere
automatically selected for subsequent collision-activated disso-
ciation. Raw files were searched using MASCOT (Matrix Sci-
ence, version 2.3.02) via Proteome Discoverer (Thermo, ver-
sion 1.3.0.339) against the sequence for mouse myosin-X
(NP_062345). Search parameters included peptide mass toler-
ance of 10 ppm, fragment ion tolerance of 0.8 mass unit, vari-
able modifications for methionine oxidation, and no enzyme
specificity. Peptides with an expectation value of less than 0.01
were considered “high confidence” matches.
In Situ Hybridization—Riboprobes to Myo10 were cloned
into the pBluescript (pBS) vector. The tail probe was described
previously (2) and corresponds to nucleotides 4862–5246 of
mouse Myo10 mRNA (NM_019472). The head probe (AR4-1)
was cloned from mouse Myo10 cDNA and corresponds to
nucleotides 1245–1739 of NM_019472. The headless probe
(AR4-2) consists of all 115 nucleotides of the predicted 5 UTR
of headlessMyo10 andwas synthesized directly and ligated into
pBS.
Embryos or brains were fixed overnight in RNase-free 4%
paraformaldehyde in 1 PBS at 4 °C. Tissue samples were
rinsed in PBS and cryoprotected by immersion through sucrose
(10 and 30% sucrose in RNase-free 1 PBS, each step overnight
at 4 °C), embedded in freezing compound, rapidly frozen on dry
ice, and stored at 80 °C. Serial cryosections were collected
onto slides (Fisher Superfrost Plus) at 16-m intervals and
stored at 80 °C before in situ hybridization. After proteinase
K pretreatment and prehybridization, 1–2 mg/ml digoxigenin-
labeled riboprobes were hybridized for 12–16 h at 65 °C. After
rinsing, sections were incubated with a 1:2000 dilution of alka-
line phosphatase-conjugated sheep anti-digoxigenin (Roche) in
blocking buffer for 3 h at room temperature and developed in a
nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate
solution (20 l/ml, Roche) in the dark overnight. After devel-
oping, sections were mounted in aqueous mounting medium
(DAKO Faramount).
Imaging and Quantification—To analyze axon outgrowth,
cultured neurons were fixed after 7 days in vitro in 4% parafor-
maldehyde in PBS for 20 min at room temperature and coun-
terstained with -tubulin III (Covance) to confirm neuronal
identity. The neurons were imaged on aNikon TE-2000micro-
scope with a 20 lens. All processes of the neuron were traced
using the ImageJ pluginNeuronJ, and analyzedwithXLNJ_Cal-
culations, a Java program that performs batch analysis of Neu-
ronJ tracing data (35). For quantification of filopodia number,
COS-7 cells were replated 2 h after transfection onto poly-L-
lysine-coated coverslips. The following morning, the cells were
fixed 20 min in 4% paraformaldehyde in PBS, permeabilized
with 0.05% Triton X-100 for 20 min, and stained with DAPI
(200 nM) for 30min. Individual, non-dividing, well isolated cells
were then imaged on a Nikon TE-2000microscope at60, and
all peripheral filopodia were counted as described previously
(7). Filopodia were defined as thin protrusions extending at
least 0.75 m.
Constructs—shRNA constructs were cloned into pSCV2, a
bicistronic vector expressing shRNA under the RNA polymer-
ase III-specific U6 promoter and Venus under the RNA poly-
merase II-specific chicken -actin promoter (36). Using the
Dharmacon siDesign Center, we selected the following targets:
full-length Myo10 shRNA #1 (AR2-1), GCAATGCGAAGA-
CAGTATA (nucleotides 1083–1101 of NM_019472 (37)); full-
length Myo10 shRNA #2 (AR2-6), GAGGAAGAATTG-
TAGATTA (nucleotides 1170–1188); headless Myo10 shRNA
#1 (AR2–3), CAGCATCTGAAGAGAGGAA (nucleotides
84–102 of the 5 UTR); and headless Myo10 shRNA #2 (AR2–
2), TGAAGAGAGGAAAGGGAAA (nucleotides 91–109 of
the 5 UTR). Results with AR2-1 and AR2-3 in Fig. 3 were con-
firmed with AR2-6 and AR2-2 in supplemental Fig. S2.
The following fluorescently tagged Myo10 constructs from
bovine Myo10 in pEGFP-C2 (Clontech) have been described
previously (7): GFP-full-length Myo10 (aa 1–2052 of bovine
Myo10 sequence U55042), GFP-headless Myo10 (aa 644–
2052), and GFP-Myo10 tail (aa 1160–2052). Bovine GFP-
Myo10 -helical region (aa 811–946) was generated by PCR
and cloned into pEGFP-C3. Bovine mCherry-full-length
Myo10 (MK1) was generated in a pEGFP-C2 modified to
express mCherry instead of EGFP. Bovine GFP-full-length
Myo10 (AR1-1) and GFP-headless Myo10 (AR1-2) were
also cloned into the pCIG2 vector, which contains a
(cDNA)-IRES-EGFP cassette under the control of a CMV
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enhancer and a chicken -actin promoter (38). Mouse GFP-
full-length Myo10 (aa 1–2062 of NP_062345), cloned into the
BglII and KpnI sites of pEGFP-C3, was a generous gift of Erich
Boger and Tom Friedman. Mouse headless Myo10 (aa 644–
2062 and the entire 115-bp 5 UTR) was cloned into pCIG2 by
replacing the sequence for aa 1–643 with a synthetic fragment
containing the 5 UTR (AR1-3).
RESULTS
Full-length and Headless Myo10 Are Expressed in Cortical
Neurons—Two isoforms of Myo10 are detected in the brain
(31), as diagrammed in Fig. 1A. Full-lengthMyo10 is expressed
ubiquitously but at low levels in most cells and tissues (2),
whereas headlessMyo10has only been identified in the nervous
system, and its function is unknown. To confirm the initiation
site of the headlessMyo10protein,we immunoprecipitated and
sequenced both headless and full-length Myo10 from P10
mouse brain. The resulting peptides are within amino acids
190–2046 for full-length Myo10 and 645–2046 for headless
Myo10.We also detect a single non-tryptic peptide from head-
less Myo10 that starts at Pro-645, strongly suggesting that the
major form of headless Myo10 indeed initiates at Met-644, as
predicted, then is processed by aminopeptidase cleavage of the
initiating methionine, leaving amino acids 645–2062 (supple-
mental Fig. S1).
Althoughwe showed previously that headless and full-length
Myo10 are developmentally regulated in the postnatal mouse
brain (31), little is known about the prenatal expression of
Myo10. Immunoblotting of mouse cortical tissue (Fig. 1B)
reveals that expression levels of both headless and full-length
Myo10 are highest at E15. In cortex, both isoforms decrease at
E18 and again at P1, resurge at P10, and then fade in adulthood.
This is consistent with our previous results showing a peak of
expression in whole cerebrum between P5 and P15 but low
levels of expression before or after (31). Interestingly, headless
Myo10 is the predominant isoform in mouse cortex at all time
points (Fig. 1B).
HeadlessMyo10 is also the predominant isoform in cultured
cortical neurons, whereas full-length Myo10 is expressed at
lower levels (Fig. 1B). Immunoblotting also demonstrates that
both full-length and headless Myo10 are expressed in embry-
onic stem cells, neural stem cells, and astrocytes. Both isoforms
are also expressed in P19 cells, a multipotent embryonic carci-
noma cell, but, like most cells, the glioblastoma cell lines U-87
and U-138 appear to express only full-length Myo10 (Fig. 1B).
In Situ Hybridization Reveals Differential Localization of
Full-length and Headless Myo10—Previous efforts to deter-
mine the localization ofMyo10 in brain have utilized antibodies
or riboprobes that cannot distinguish between full-length and
headless Myo10 (2, 31, 39–41). Because the protein sequence
of headless Myo10 initiates at amino acid 644 but thereafter is
identical to full-lengthMyo10, generation of a headless-specific
antibody is unlikely. However, headless Myo10 is transcribed
from an alternate start site, giving it a unique 5 UTR of 115
nucleotides (31). We used this 5 UTR to generate a riboprobe
for headless Myo10, which, along with probes to the head and
tail ofMyo10 (diagrammed in Fig. 1A), allowed us to determine
the localization of each isoform. Sense control probes con-
firmed the absence of nonspecific labeling (data not shown). In
coronal sections of E15 embryos, the tail probe, which should
recognize transcripts of both isoforms, shows strong labeling in
the ventricular zone (Fig. 2,A and B), the location of neurogen-
esis and gliogenesis in the developing brain. This is consistent
with data from an in situ hybridization database using a probe
to the tail of Myo10, which showed expression primarily in the
FIGURE 1. Full-length and headless Myo10 are expressed in embryonic cortical neurons. A, domain representation of the mouse sequence of full-length
(NCBI, NP_062345.2) and headless Myo10 showing the recognition sequence of the anti-Myo10 antibody (Sigma, HPA024223), riboprobes (blue) and RNAi
targets (red) used in this study. For the purposes of illustration, the 115-bp 5 UTR of headless Myo10 is included. Amino acid numbers are shown for the
beginning and end of each protein. IQ, IQ motifs; PEST, region enriched in proline, glutamine, serine, and threonine; PH, pleckstrin homology domain; MyTH4,
myosin tail homology 4 domain; FERM, band 4.1/ezrin/radixin/moesin domain. B, immunoblotting of cortical tissue and cultured cells reveals expression of
both isoforms. Both headless and full-length Myo10 are also expressed in embryonic stem cells, neural stem cells, astrocytes, and multipotent P19 cells, but, like
most cells, the glioblastoma cell lines U-87 and U-138 only express full-length Myo10.
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ventricular zone of the embryonic brain (40). We also detect
expression in the developing cortical plate and brain vascula-
ture. Outside the brain, strong labeling is observed in the epi-
thelium of the tongue and in muscle tissues.
The head probe shows similar labeling of non-neuronal tis-
sues, but in the E15 brain, the strongest labeling is detected in
blood vessels (Fig. 2, H and I). A weaker signal is detectable in
the cortical plate. Because the tail probe strongly labels the ven-
tricular zone but the head probe shows little to no signal in this
region, we conclude that full-length Myo10 is primarily
expressed in developing blood vessels and neurons, whereas
headless Myo10 is most abundant in the ventricular zone. This
conclusion is supported by the headless probe, which labels the
ventricular zone, although it gives a weaker signal, probably
because of its shorter length (Fig. 2, O and P).
Sagittal sections of P8 brain reveal continued expression of
Myo10 in the cortical plate, where neurons at this stage are
differentiating and forming synapses (Fig. 2C). However,
Myo10 is expressed most strongly in two regions of active cell
division andmigration: the rostral migratory stream (RMS, Fig.
2E) and the external and internal granule cell layers of the cer-
ebellum (D). Previous results with a probe to the tail of Myo10
also suggested that Myo10 is abundant in these regions at P7
(40). The external granule cell layer consists of granule cerebel-
lar precursors undergoing rapid proliferation before migrating
inwards to form the internal granular layer (42). Consistent
FIGURE 2. Localization of full-length and headless Myo10 in the developing mouse brain. Coronal sections of E15 mouse embryos (left panels), sagittal
sections of P8 brains (center panels), and coronal sections of adult hindbrain (right panels), labeled with riboprobes to the tail region to detect both isoforms
(A–G), the head region to detect full-length Myo10 (H–N), and the 5 UTR of headless Myo10 to specifically detect headless Myo10 (O–U). In E15 brains,
full-length Myo10 is most intensely expressed in blood vessels, whereas headless Myo10 is strongest in the ventricular zone. At P8, full-length Myo10 is strongly
expressed in the external and internal granular layers of the cerebellum (EGL and IGL), whereas both isoforms appear to be expressed in the olfactory bulb, RMS,
and the anterior portion of the ventricular zone. In the adult brain, full-length Myo10 is primarily expressed in Purkinje cells of the cerebellum. EGL, external
granular layer, IGL, internal granular layer, ML, molecular layer, GL, granular layer.
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with our previousWestern blotting results withmouse cerebel-
lum (31), the tail and head probes, but not the headless probe,
show strong labeling in the cerebellum, indicating expression of
primarily full-length Myo10. The RMS is a population of neu-
ronal precursorsmigrating from their birthplace in the subven-
tricular zone to the olfactory bulb (43). The tail probe labels the
RMS more strongly than the head probe, and the headless
probe shows clear labeling of this region, indicating thatMyo10
expression in the RMS is largely due to headless Myo10.
In adult brain sections, Myo10 is strongly expressed in the
cerebellum, particularly in Purkinje cells (Fig. 2F), consistent
with our previous blotting and in situ hybridization results (2,
31). This expression is detected by the head and tail probes, but
not the headless probe, indicating that it is largely due to full-
length Myo10 (Fig. 2).
Knockdown of Full-length andHeadlessMyo10HasOpposing
Effects on Axon Outgrowth and Branching—Because both iso-
forms ofMyo10 are expressed in cortical neurons, we set out to
determine the specific functions of full-length and headless
Myo10 in neuronal development. We targeted full-length
Myo10 for RNAi using a sequence from the motor domain (37)
and utilized the unique 5 UTR of headless Myo10 to specifi-
cally knock down headless Myo10 (Fig. 1A). shRNAs for these
targets were cloned into a bicistronic vector expressing the
shRNA under the RNA polymerase III-specific U6 promoter
andVenus under the RNApolymerase II-specific chicken-ac-
tin promoter (36).We confirmed specific knockdown inCOS-7
cells cotransfected with both full-length and headless Myo10
(Fig. 3F).
We then tested these shRNA sequences in cortical neuron
cultures and measured the effects on neuronal morphology.
Cortices from E15 mice were electroporated with the shRNA
constructs, dissociated, and the neurons grown in culture on
poly-L-lysine and laminin for 7 days. To determine axon out-
growth,wemeasured the length and the number of branches on
the longest neurite for each neuron. Knockdown of full-length
Myo10 decreases axon outgrowth by 37% compared with
nonspecific shRNA (Fig. 3, B and D) and reduces branching by
27% (E). Knockdown of headlessMyo10 has opposing effects,
nearly doubling axon outgrowth and increasing the number of
branches by 50% over control neurons (Fig. 3, C–E).
Although knockdown of headless and full-length Myo10 had
opposite effects on the total number of branches, we did not
detect an effect on branch density. To confirm the specificity of
these effects, we used a second set of shRNAs targeting headless
and full-length Myo10, producing similar effects on axon mor-
phology (supplemental Fig. S2).
Overexpression of Full-length Myo10 Stimulates Axon Out-
growth and Branching, whereas Headless Myo10 Inhibits Axon
Outgrowth and Branching—Zhu et al. (28) reported that a
motorless Myo10 construct suppressed axon outgrowth from
cortical explants but that this construct only included amino
acids 860–2062. Because endogenous headless Myo10 begins
with Pro-645, it includes an additional 215 amino acids from
the motor, IQ, and -helical regions (Fig. 1A). We thus tested
whether overexpression of the native headless Myo10 would
inhibit axon outgrowth in cultured neurons. Using the same
techniques to transfect and culture cortical neurons as in our
knockdown experiments above, we determined that overex-
pression of GFP-tagged headless Myo10 indeed inhibits axon
outgrowth by58% comparedwithGFP alone (Fig. 4,C andD).
FIGURE 3. Knockdown of full-length Myo10 inhibits axon outgrowth and branching, whereas knockdown of headless Myo10 increases axon out-
growth and branching. To test the function of each isoform of Myo10, we developed shRNA constructs specific to each isoform and transfected them into
cortical neurons. The neurons were dissociated from E15 cortex and cultured for 7 days. A–C, representative single neurons transfected with each shRNA and
imaged at 20 magnification. Scale bars  30 m. D, quantification of the length of the longest neurite on each neuron. Whiskers, 5–95%; boxes, 25–75%;
middle lines, median; , mean; ***, p  0.0001. The means and S.E. are as follows: nonspecific shRNA, 366  18 m; full-length shRNA, 230  15 m; and
headless shRNA, 624  52 m. E, quantification of the mean number of branches on the longest neurite of each neuron. Error bars represent mean  S.E.
*, indicates p  0.05. The means and S.E. are as follows: nonspecific shRNA, 6.6  0.4 branches; full-length shRNA, 4.83  0.5 branches; and headless shRNA,
10.4  0.8 branches. F, immunoblot of COS-7 cells cotransfected with GFP-full-length Myo10, headless Myo10, and the indicated shRNA. The full-length Myo10
shRNA targets the motor domain. The headless Myo10 shRNA targets the 5 UTR, which is unique.
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Overexpression of headlessMyo10 also decreases branching by
45% (Fig. 4, C and E).
On average, overexpression of full-length Myo10 increases
both outgrowth and branching by50% (Fig. 4,B andD). How-
ever, neurons transfected with full-length Myo10 exhibit a
broad range of axon lengths, andmany have shorter axons than
control neurons. These shorter axons are highly branched and
may be associatedwith higher levels of expression of full-length
Myo10 (supplemental Fig. S3), raising the possibility that full-
length Myo10 promotes outgrowth at low levels but has dele-
terious effects at higher levels.
HeadlessMyo10 Is aNegative Regulator of Full-lengthMyo10—
Since the discovery of headless Myo10, it has been widely
hypothesized to function as an endogenous dominant negative
of the full-length protein (28, 30, 31). This is consistentwith our
knockdown results showing opposite effects of full-length and
headless Myo10 on axon outgrowth. To directly test whether
headless Myo10 antagonizes full-length Myo10, we turned to a
key function of full-length Myo10: filopodia induction. It has
been shown previously that overexpression of full-length
Myo10 in COS-7 cells increases the number of substrate-at-
tached filopodia (5, 7, 10, 11, 27). Consistent with these previ-
ous studies, overexpression of full-length Myo10 led to a
4-fold increase in substrate-attached filopodia (Fig. 5, A and
E). On the other hand, overexpression of headless Myo10 has
no significant effect on the baseline number of filopodia on
COS-7 cells (Fig. 5E). However, coexpression of headless
Myo10 with full-length Myo10 prevents the induction of filo-
podia by full-lengthMyo10 (Fig. 5,B andE), demonstrating that
headless Myo10 can indeed antagonize the filopodia-inducing
activity of full-length Myo10.
The structure of Myo10 suggests two mechanisms by which
headless Myo10 may negatively regulate full-length Myo10.
First, headless Myo10 may inhibit the activity of full-length
Myo10 by forming heterodimers with only one motor domain.
We and others have provided evidence that dimerization to
forma two-headedmotor is necessary for themotility ofMyo10
on actin filaments (5, 7, 10, 44). Second, because headless
Myo10 includes all of the tail domains of Myo10, the headless
isoform might also act by competing for cargoes with full-
length Myo10. Without any motor activity of its own, headless
Myo10 could not transport these cargoes to their appropriate
destinations. To test the first hypothesis, we coexpressed full-
lengthMyo10with the-helical region ofMyo10 (Fig. 5D), part
of which forms a stable -helix that lengthens the lever arm
(45), whereas the remainder has been implicated in dimeriza-
tion (5, 9, 10, 44). Coexpression of this -helical region dramat-
ically suppresses the induction of filopodia by full-length
Myo10 (Fig. 5, D and E). To test the second hypothesis, we
cotransfected full-length Myo10 with a Myo10 construct that
includes the cargo-binding tail region but not the -helical
region (Fig. 5C), which also reduces the induction of filopodia
(C and E). These results strongly suggest that headless Myo10
can antagonize full-lengthMyo10 both by dimerizing with full-
length Myo10 and by sequestering cargoes away from the
motor.
DISCUSSION
In this studywehave focused onheadlessMyo10,which lacks
a functional motor domain, the defining feature of myosins.
Headless Myo10 had been observed previously only in the ner-
vous system, but its function had not been tested.We generated
a shRNA specific to the 5UTRof headlessMyo10 to determine
the function of headless Myo10 in cortical neurons. Expression
of this shRNA leads to dramatically increased axon outgrowth
and branching, suggesting that headless Myo10 normally acts
to inhibit these processes. Indeed, overexpression of headless
Myo10 decreases axon outgrowth and branching, consistent
with previous reports of decreased axon outgrowth using a
shorter motorless Myo10 construct (28).
On the other hand, knockdown of full-length Myo10
decreases axon outgrowth and branching. This result suggests
that previous data showing a requirement for Myo10 in com-
missural axon crossing in chick spinal cord (28) may reflect
insufficient outgrowth rather than mistargeting of axons.
Somewhat surprisingly, overexpression of full-length Myo10
does not uniformly produce longer axons but, rather, a broad
range of axon lengths. This effectmay be due to varying levels of
FIGURE 4. Overexpression of full-length Myo10 stimulates axon outgrowth and branching, whereas headless Myo10 inhibits axon outgrowth and
branching. Neurons were transfected and cultured as in Fig. 3. A–C, representative neurons imaged at 20. Scale bars  30 m. D, quantification of the length
of the longest neurite on each neuron. Whiskers, 5–95%; boxes, 25–75%; middle lines, median; , mean; *, indicates p  0.05; **, p  0.001. The means and S.E.
are as follows: GFP, 309  32 m; GFP-Myo10 full-length, 465  63 m; and GFP-Myo10 headless, 129  14 m. E, quantification of the mean number of
branches on the longest neurite of each neuron. Error bars  mean  S.E. The means and S.E. are as follows: GFP, 10.7  1.3 branches; GFP- Myo10 full-length,
16.0  1.9 branches; GFP-Myo10 headless, and 5.91  0.6 branches.
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overexpression. Too much full-length Myo10 may generate
excess filopodia, aberrant branches, and shorter axons.
Together, these results show that full-lengthMyo10 is required
for protrusion of growth cones and branches, whereas headless
Myo10 opposes the activity of full-length Myo10.
To directly demonstrate that headlessMyo10 can antagonize
full-length Myo10, we coexpressed the proteins in COS-7 cells
andquantified the number of filopodia.HeadlessMyo10 indeed
suppresses the induction of filopodia by full-length Myo10.
Coexpression of the -helical region also inhibits filopodia
induction by full-length Myo10, and from this, we conclude
that headless Myo10 likely dimerizes with full-length Myo10,
forming a one-headed, two-tailedmotor incapable of localizing
to filopodia. Although a previous study showed that the -heli-
cal region is sufficient to suppress dorsal filopodia in HeLa cells
(11), in this study, expression of the -helical region does not
affect the number of substrate-attached filopodia on COS-7
cells at baseline. This differencemay result from the small num-
ber of filopodia on control COS-7 cells (14 substrate-attached
filopodia/cell), whereas HeLa cells elaborate huge numbers of
dorsal filopodia at baseline (851 dorsal filopodia/cell) (11).
Alternatively, the difference may reflect a fundamental distinc-
tion between dorsal and substrate-attached filopodia. Our
results also show that the tail region of Myo10 is effective in
counteracting filopodia induction by full-length Myo10, sug-
gesting that headless Myo10 may compete with full-length
Myo10 for binding partners.
So, if headless Myo10 is a negative regulator of full-length
Myo10, what is the function of full-length Myo10 in growing
axons? One obvious possibility is that full-length Myo10 is
required for the formation or function of growth cone filopodia,
which are crucial structures for growth cone motility and sig-
naling (14). Filopodia are also key prerequisites for neurite ini-
tiation in cortical neurons (12).We do not detect a requirement
for Myo10 in neurite initiation in our experiments, probably
because knockdown of Myo10 does not occur until after neu-
rites have formed. Future studies, perhaps utilizing genetic
knockout of Myo10, will be needed to test whether Myo10 is
required for neurite initiation.
Myo10 may also serve to transport cargoes within growth
cone filopodia. Myo10 can bind to the netrin receptors DCC
and neogenin (6, 23, 28, 29) and is required to localize DCC to
neurites (28). However, in this study, outgrowth was not stim-
ulated by any exogenous guidance cue or growth factor, indi-
cating that Myo10 is required for baseline axon outgrowth
independent of external cues.
The FERM domain of Myo10 can also bind -integrins (27),
adhesionmolecules thatmediate interactionswith the extracel-
lularmatrix. Full-lengthMyo10 could couple these interactions
to the actin cytoskeleton, a proposedmechanism for generating
protrusive force at the leading edge (46). Full-lengthMyo10 can
also link the actin andmicrotubule cytoskeletonswith itsmotor
and MyTH4 domains, respectively. Myo10 has been shown to
mediate such interactions in mitotic andmeiotic spindles (19–
21), but it is unclear whether Myo10 participates in actin-mi-
crotubule interactions in growth cones. Because headless
Myo10 lacks a functional motor domain, it cannot bind actin
filaments, but it will be important to determine whether full-
lengthMyo10 acts to link growth cone actin filaments tomicro-
tubules or integrins.
Our results also implicate Myo10 in axon branching. This is
not surprising, asmany of the cytoskeletal processes underlying
axon outgrowth and guidance are shared with axon branching
(47), including the importance of filopodia and actin-microtu-
bule interactions (24). Another mechanism shared between
these two processes is regulation by PI3K. This kinase is a con-
FIGURE 5. Headless Myo10 is a negative regulator of full-length Myo10. To test whether headless Myo10 antagonizes full-length Myo10, we measured
filopodia induction in COS-7 cells grown on poly-L-lysine-coated glass. A–D, representative COS-7 cells transfected with mCherry-Myo10 full-length and either
GFP (A), GFP-Myo10 headless (B), GFP-Myo10 tail (C), or GFP-Myo10 -helical (D). E, quantification of substrate-attached filopodia/cell for cells transfected with
the indicated constructs. Error bars  S.E. ns, not significant. ***, indicates p  0.0001, n  40 cells per condition. F, bar diagram of constructs used to transfect
COS-7 cells.
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vergence point in axon guidance pathways, whereas localized
activity of PI3K along the axon shaft forms patches of actin that
precede axonal filopodia and, in turn, enlarge to become full-
fledged branches (48). Recent in vitrowork shows thatMyo10 is
autoinhibited until binding to the PI3K product phosphatidyl-
inositol (3,4,5)-triphosphate (5), suggesting that Myo10 can
link the PI3K pathway to the actin cytoskeleton.
Although we have shown that headless Myo10 can act as a
negative regulator of full-lengthMyo10, we cannot exclude the
possibility that headless Myo10 has functions independent of
the full-length isoform. In fact, a gene with a domain structure
remarkably similar to headless Myo10 was discovered in
Caenorhabditis elegans (49). Loss of this gene, max-1, led to
defects in motor axon guidance and decreased coordination.
The MAX-1 protein, which includes the coiled-coil, PH,
MyTH4 and FERM domains, appeared to participate in netrin-
mediated axon repulsion. Recent evidence suggests that, in ver-
tebrates, the primary function of MAX-1 may be in angiogene-
sis (50). These studies suggest future avenues for investigation
of headless Myo10.
The expression pattern we observed in this study also sug-
gests novel and unexpected functions for Myo10. Our immu-
noblotting and in situ hybridization reveal that headlessMyo10
is expressed in the developing mouse cortex in neurons and
astrocytes but is also abundant in neural stem cells. Although
full-length Myo10 is also detected in neural stem cells, Myo10
expression in the embryonic ventricular zone and the postnatal
rostral migratory stream appears to be primarily due to head-
lessMyo10. This suggests a new and surprising role for headless
Myo10 in neurogenesis. A number of studies have identified a
role for full-length Myo10 in mitotic and meiotic spindles (20,
21), including integrin-dependent spindle orientation (19).
Spindle orientation is thought to be important for cell fate
determination in neural progenitor mitosis (51, 52), and 1-in-
tegrin adhesion is required for normal neurogenesis in this cell
population (53). HeadlessMyo10 has not been previously asso-
ciated with spindle function, but the strong expression in the
ventricular zone suggests that it may be important for neuro-
genesis, and further work is warranted to test this possibility.
We were also intrigued to find that in the embryonic brain,
full-length Myo10 strongly labels the developing vasculature,
raising the possibility of a role for Myo10 in angiogenesis. A
previous study found a requirement for Myo10 in guiding
endothelialmigration toward a BMP6 gradient (37), so it will be
important to test whether Myo10 participates in endothelial
cell migration and angiogenesis in vivo.
Myo10 has been shown to function in migration of another
cell type in vivo: cranial neural crest cells (54, 55). Morpholino-
mediated knockdown of Myo10 during early Xenopus laevis
development slowed neural crest cell migration and impaired
the formation of pharyngeal arch structures. Myo10 knock-
down also decreased filopodia and adhesions when the cells
were cultured in vitro. Similarly, experiments with NLT cells, a
neuronal cell line, showed that overexpression of a motorless
Myo10 construct decreased migration and focal adhesion for-
mation (30). The enrichment of Myo10 that we observed in the
rostral migratory stream of the postnatal brain suggests that
Myo10 may be important for the migration of some popula-
tions of neurons in the brain.
Finally, given the importance of filopodia in dendritic spine
formation (56, 57), it will be important to investigate the role of
Myo10 in dendritic spines. Future studies of the functions of
Myo10 in the nervous system would benefit greatly from a
genetic knockout of Myo10, but, given the distinct and oppos-
ing functions of full-length and headlessMyo10 outlined in this
study, it will also be important to selectively delete the headless
isoform. This would allow determination of the in vivo func-
tions of this unusual isoform. Investigating the role of headless
Myo10 in stem cells will be of particular interest.
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